¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼¼°è »À¼ºÀå ÀÚ±Ø ½ÃÀå ±Ô¸ð´Â 2024³â 4¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 3.1%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2031³â¿¡´Â ¾à 4¾ï 9,500¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼ºÀå ÃËÁø¿äÀÎÀº ´ÙÀ½°ú °°½À´Ï´Ù:
- °ñÀ¯ÇÕ¼ú°ú ºñÀ¯ÇÕ °ñÀýÀÇ Áõ°¡ Áõ°¡
- ÈÞ´ë °¡´ÉÇÑ È¯ÀÚ Ä£ÈÀû ÀåÄ¡ ±â¼ú °³¹ß
- ¿Ü°úÀû °³ÀÔÀ» ´ëüÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀû ¹æ¹ý¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
- º» º¸°í¼¿¡´Â ´ÙÀ½°ú °°Àº ³»¿ëÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù:
- Àü±âÀû »À¼ºÀå Àڱرâ
- ÃÊÀ½ÆÄ »À¼ºÀå Àڱرâ
½ÃÀå º¸°í¼ µ¥ÀÌÅÍ À¯Çü
- ÆÇ¸Å·® ¹× Æò±ÕÆÇ¸Å°¡°Ý(ASP)
- ½ÃÀå ±Ô¸ð ¹× ¼ºÀå µ¿Çâ
- 2031³â±îÁö ½ÃÀå ¿¹Ãø
- °ú°Å µ¥ÀÌÅÍ(2021-2024³â)
- ½ÃÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
- ÇÕº´ ¹× ÀμöÇÕº´
- °æÀï»ç ÇÁ·ÎÇÊ ¹× Á¦Ç° Æ÷Æ®Æú¸®¿À
¼¼°è »À¼ºÀå ÀÚ±Ø ½ÃÀå µ¿Çâ
- ÁÖ¿ä µ¿ÇâÀº Ä¡·á È¿°ú¿¡ ÇʼöÀûÀΠȯÀÚ ¼øÀÀµµ Çâ»ó, »ç¿ëÇϱ⠽¬¿î ±â±â·ÎÀÇ °·ÂÇÑ ÀüȯÀÔ´Ï´Ù.
- ±â¾÷µéÀº ¼øÀÀµµ¿Í ÀÓ»ó °á°ú¸¦ °³¼±Çϱâ À§ÇØ »ç¿ëÇϱ⠽¬¿î µðÀÚÀο¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.
- ȯÀÚ¿ÍÀÇ °ü°è ¹× Ä¡·á È¿°ú¸¦ ³ôÀ̱â À§ÇØ ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀ» žÀçÇÑ ÀÇ·á±â±â°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå Á¡À¯À² ÀλçÀÌÆ®(2024³â)
- Bioventus - ½ÃÀå ¸®´õ
- Exogen(R) ÃÊÀ½ÆÄ »À Ä¡·á ½Ã½ºÅÛÀ¸·Î ¼¼°è ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù.
- ÃÊÀ½ÆÄ ÀÚ±Ø ºÎ¹® µ¶Á¡
- ºÏ¹Ì, ¼À¯·´¿¡¼ ³ôÀº ½ÃÀå Á¡À¯À²À» ÀÚ¶ûÇϸç Àü ¼¼°èÀûÀ¸·Î Á¸Àç°¨À» ³ôÀ̰í ÀÖ½À´Ï´Ù.
- ZimVie/Highridge Medical - 2À§ °æÀï»ç
- ³»ºÎ »À¼ºÀå Àڱرâ OsteoGen(R) Á¦°ø
- ½ÃÀå À¯ÀÏÀÇ ÁÖ¸ñÇÒ ¸¸ÇÑ ³»ºÎ ÀÚ±Ø ½Ã½ºÅÛ
- Àü ¼¼°èÀûÀ¸·Î ¾ÈÁ¤ÀûÀÎ ÀÔÁö¸¦ À¯ÁöÇϰí ÀÖÀ¸¸ç, ¾ÕÀ¸·Îµµ ±× ÁöÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- Orthofix - 3À§ °æÀï»ç
- PhysioStim(TM) ¿ÜºÎ ÀÚ±Ø ÀåÄ¡·Î À¯¸íÇÕ´Ï´Ù.
- Àåºñ ¼³°èÀÇ Çõ½ÅÀÌ °è¼ÓµÇ´Â °¡¿îµ¥, ½ÃÀå Á¡À¯À² È®´ë°¡ ±â´ëµË´Ï´Ù.
- ü¿Ü ºñħ½ÀÀû Ä¡·á¿¡ ÃÊÁ¡À» ¸ÂÃá ½ÃÀå¿¡¼ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¼¼ºÐÈ ¿ä¾à
- ÃÊÀ½ÆÄ »À¼ºÀå Àڱر⠽ÃÀå
- Àü±â »À¼ºÀå Àڱر⠽ÃÀå
Á¶»ç ¹üÀ§ ¿ä¾à
- ´ë»ó Áö¿ª
- ºÏ¹Ì : ij³ª´Ù, ¹Ì±¹
- ¶óƾ¾Æ¸Þ¸®Ä« : ¾Æ¸£ÇîÆ¼³ª, º¼¸®ºñ¾Æ, ºê¶óÁú, Ä¥·¹, ÄÝ·Òºñ¾Æ, ÄÚ½ºÅ¸¸®Ä«, µµ¹Ì´ÏÄ« °øÈ±¹, ¿¡Äâµµ¸£, °úÅ׸»¶ó, ¸ß½ÃÄÚ, ÆÄ³ª¸¶, ÆÄ¶ó°úÀÌ, Æä·ç, Ǫ¿¡¸£Å丮ÄÚ, ¿ì·ç°úÀÌ, º£³×¼ö¿¤¶ó
- ¼À¯·´ : ¿À½ºÆ®¸®¾Æ, º£³×·è½º, ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, Æ÷¸£Åõ°¥, ½ºÄµð³ªºñ¾Æ, ½ºÆäÀÎ, ½ºÀ§½º, ¿µ±¹
- ÁßÀ¯·´ ¹× µ¿À¯·´ : ¾ÆÁ¦¸£¹ÙÀÌÀÜ, ¹ßÆ® 3±¹, º§¶ó·ç½º, ºÒ°¡¸®¾Æ, Å©·Î¾ÆÆ¼¾Æ, üÄÚ, Á¶Áö¾Æ, ±×¸®½º, Çë°¡¸®, Ä«ÀÚÈ彺ź, Æú¶õµå, ·ç¸¶´Ï¾Æ, ·¯½Ã¾Æ, ¼¼¸£ºñ¾Æ, ½½·Î¹ÙŰ¾Æ, ½½·Îº£´Ï¾Æ, Æ¢¸£Å°¿¹, ¿ìÅ©¶óÀ̳ª
- Áßµ¿ : ¹Ù·¹ÀÎ, À̶õ, À̽º¶ó¿¤, Äí¿þÀÌÆ®, ¿À¸¸, īŸ¸£, »ç¿ìµð¾Æ¶óºñ¾Æ, ¾Æ¶ø¿¡¹Ì·¹ÀÌÆ®
- ¾Æ½Ã¾ÆÅÂÆò¾ç : È£ÁÖ, įº¸µð¾Æ, Áß±¹, È«Äá, Àεµ, Àεµ³×½Ã¾Æ, ÀϺ», ۸£±â½º½ºÅº, ¸¶Ä«¿À, ¸»·¹À̽þÆ, ¸ù°ñ, ¹Ì¾á¸¶, ´ºÁú·£µå, ÆÄŰ½ºÅº, Çʸ®ÇÉ, ½Ì°¡Æ÷¸£, Çѱ¹, ½º¸®¶ûÄ«, ´ë¸¸, ű¹, ¿ìÁŰ½ºÅº, º£Æ®³²
- ¾ÆÇÁ¸®Ä« : ¾ËÁ¦¸®, ÀÌÁýÆ®, ¿¡Æ¼¿ÀÇǾÆ, °¡³ª, ÄɳÄ, ¸®ºñ¾Æ, ¸ð·ÎÄÚ, ³ªÀÌÁö¸®¾Æ, ³²¾ÆÇÁ¸®Ä«°øÈ±¹, ¼ö´Ü, ¿ì°£´Ù
- ±âÁØ ¿¬µµ : 2023³â
- ¿¹Ãø ±â°£ : 2025-2031³â
- °ú°Å µ¥ÀÌÅÍ : 2021-2023³â
Á¤·®Àû µ¥ÀÌÅÍ Ä¿¹ö¸®Áö
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå ¼ºÀå·ü
- ÆÇ¸Å·®
- Æò±ÕÆÇ¸Å°¡°Ý(ASP)
- ½ÃÀå Á¡À¯À²
Á¤¼ºÀû µ¥ÀÌÅÍ
- ½ÃÀå ÃËÁø¿äÀΰú ½ÃÀå ¾ïÁ¦¿äÀÎ
- ÁÖ¿ä °æÀï»ç SWOT ºÐ¼®
- Á¦Ç° Æ÷Æ®Æú¸®¿À ¹× ±â¾÷ °³¿ä
- ÇÕº´ ¹× ÀμöÇÕº´
- FDA ¸®Äݰú ÆÄ±«Àû ±â¼ú ºÐ¼®
- °ñÀ¯ÇÕ ¹× °ü·Ã ÁúȯÀÇ °³¿ä
µ¥ÀÌÅÍ ¼Ò½º
- ¾÷°è Àü¹®°¡¿ÍÀÇ 1Â÷ ÀÎÅͺä
- Á¤ºÎ ¹× ÀÇ»ç ±â·Ï
- ±ÔÁ¦ ´ç±¹ ½Å°í
- º´¿ø Á¶´Þ µ¥ÀÌÅͺ£À̽º
- ¼öÃâÀÔ ±â·Ï
- »ç³» µ¥ÀÌÅͺ£À̽º
¼¼°èÀÇ »À¼ºÀå ÀÚ±Ø ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ºÐ¼® ¹× ¿¹Ãø, ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
¸ñÂ÷
»À¼ºÀå ÀÚ±Ø ½ÃÀå
ÁÖ¿ä ¿ä¾à
- ¼¼°èÀÇ »À¼ºÀå ÀÚ±Ø ½ÃÀå °³¿ä
- °æÀï ºÐ¼®
- ½ÃÀå ¼¼ºÐÈ
- ´ë»ó Áö¿ª
¼Ò°³
½ÃÀå °³¿ä
½ÃÀå ºÐ¼®°ú ¿¹Ãø
- »À¼ºÀå ÀÚ±Ø ½ÃÀå Àüü
- ÃÊÀ½ÆÄ »À¼ºÀå ÀÚ±Ø ½ÃÀå
- Àü±â »À¼ºÀå ÀÚ±Ø ½ÃÀå
ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
°æÀï ½ÃÀå Á¡À¯À² ºÐ¼®
ksm 25.05.14
The global bone growth stimulation market was valued at $400 million in 2024 and is projected to grow at a CAGR of 3.1%, reaching approximately $495 million by 2031.
Growth is fueled by:
- A rise in bone healing procedures and non-union fractures
- Technological developments in portable, patient-friendly devices
- Increasing awareness of non-invasive alternatives to surgical intervention
- The full report suite includes:
- Electrical Bone Growth Stimulators
- Ultrasound Bone Growth Stimulators
Market Report Data Types Included
- Unit Sales & Average Selling Prices (ASP)
- Market Size & Growth Trends
- Market Forecasts to 2031
- Historical Data (2021-2024)
- Market Drivers & Limiters
- Mergers & Acquisitions
- Competitor Profiles & Product Portfolios
Global Bone Growth Stimulation Market Trends
- The key trend is a strong industry shift toward user-friendly devices that enhance patient compliance, which is essential to the efficacy of these treatments
- Companies are investing in ease-of-use designs to improve adherence and clinical outcomes
- A growing number of devices now feature remote monitoring capabilities to boost engagement and results
Market Share Insights (2024)
- 1 Bioventus - Market Leader
- Leads the global market through its Exogen(R) ultrasound bone healing system
- Dominates the ultrasound stimulation segment
- Strong market share in North America, Western Europe, and a growing presence globally
- 2 ZimVie / Highridge Medical - Second Leading Competitor
- Offers the OsteoGen(R) internal bone growth stimulator
- The only notable internal stimulation system on the market
- Maintains a steady global presence and is expected to retain its position
- 3 Orthofix - Third Leading Competitor
- Known for the PhysioStim(TM) external stimulator
- Well-positioned to expand market share as innovation in device design continues
- Gaining attention in markets focused on external, non-invasive therapies
Market Segmentation Summary
- Ultrasound Bone Growth Stimulator Market
- Electrical Bone Growth Stimulator Market
Research Scope Summary
- Regions Covered
- North America: Canada, United States
- Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
- Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
- Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
- Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
- Asia Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
- Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
- Base Year: 2023
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Data Coverage
- Market Size & Forecasts
- Market Growth Rates
- Unit Sales
- Average Selling Prices (ASP)
- Market Shares
Qualitative Data Coverage
- Growth Drivers & Market Limiters
- SWOT Analysis of Key Competitors
- Product Portfolios & Company Profiles
- Mergers & Acquisitions
- FDA Recalls & Disruptive Technology Analysis
- Bone Healing & Related Disease Overviews
Data Sources
- Primary Interviews with Industry Experts
- Government & Physician Records
- Regulatory Filings
- Hospital Procurement Databases
- Import/Export Records
- Internal Database by iData Research
TABLE OF CONTENT
Bone Growth Stimulation Market
- 13.1 Executive Summary
- 13.1.1 Global Bone Growth Stimulation Market Overview
- 13.1.2 Competitive Analysis
- 13.1.3 Market Segmentation
- 13.1.4 Regions Included
- 13.2 Introduction
- 13.3 Market Overview
- 13.3.1 By Segment
- 13.3.2 By Region
- 13.4 Market Analysis and Forecast
- 13.4.1 Total Bone Growth Stimulation Market
- 13.4.2 Ultrasound Bone Growth Stimulation Market
- 13.4.3 Electrical Bone Growth Stimulation Market
- 13.5 Drivers and Limiters
- 13.5.1 Market Drivers
- 13.5.2 Market Limiters
- 13.6 Competitive Market Share Analysis